Durham, NC, United States of America

Parisa Yousefpour

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Duke University. Active years: 2022-2026.


% Patents Active = 66.7

 

Average Co-Inventor Count = 2.7

ph-index = 1


Company Filing History:


Years Active: 2022-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Parisa Yousefpour: Innovator in Drug Delivery Systems

Introduction

Parisa Yousefpour is a prominent inventor based in Durham, NC (US). She has made significant contributions to the field of drug delivery systems, holding 3 patents that showcase her innovative approach to enhancing therapeutic efficacy.

Latest Patents

Her latest patents include "Albumin binding peptide-drug (AlBiPeD) conjugates and methods of making and using same." This patent describes albumin binding peptide drug conjugates that comprise a small molecule linked to an albumin binding domain via a pH-sensitive linker, along with methods for purifying and utilizing these conjugates. Another notable patent is "Genetically encoded intrinsically disordered stealth polymers for delivery and methods of using same." This invention provides conjugates that include a polypeptide and one or more drug molecules, designed to effectively deliver the drug molecule to a subject.

Career Highlights

Parisa Yousefpour is affiliated with Duke University, where she continues to advance her research in drug delivery technologies. Her work is characterized by a commitment to improving patient outcomes through innovative solutions.

Collaborations

She collaborates with esteemed colleagues such as Ashutosh Chilkoti and Samagya Banskota, contributing to a dynamic research environment that fosters innovation.

Conclusion

Parisa Yousefpour's contributions to drug delivery systems exemplify her dedication to innovation in the medical field. Her patents reflect a forward-thinking approach that has the potential to significantly impact therapeutic practices.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…